Human telomerase reverse transcriptase (hTERT) gene expression in thyroid carcinoma: diagnostic and prognostic role.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of the Egyptian National Cancer Institute

• Publication date

  2006-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 17237847
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thyroid carcinoma.

  2007cited by this paper
• Telomeres, telomerase, and apoptosis.

  2004cited by this paper
• Implications of Prognostic Factors and Risk Groups in the Management of Differentiated Thyroid Cancer

  2004cited by this paper
• Alternative lengthening of telomeres: dangerous road less travelled.

  2003cited by this paper
• Detection of telomerase expression in mediastinal lymph nodes of patients with lung cancer.

  2003cited by this paper
• Clinical application of human telomerase reverse transcriptase gene expression in thyroid follicular tumors by fine-needle aspirations using in situ hybridization.

  2003cited by this paper
• Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms.

  2003cited by this paper
• Expression of telomerase genes in thyroid carcinoma.

  2002cited by this paper
• Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues.

  2001cited by this paper
• Telomerase and cancer.

  2001cited by this paper
• Switching and signaling at the telomere.

  2001cited by this paper
• Telomerase activity and telomere length in thyroid neoplasia: biological and clinical implications

  2001cited by this paper
• Evaluation of telomerase activity in cutaneous melanocytic proliferations.

  2000cited by this paper
• Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma

  2000cited by this paper
• Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma

  2000cited by this paper
• Telomerase Activity in Thyroid Malignancy

  1999cited by this paper
• Telomerase activity in renal cell carcinoma

  1999cited by this paper
• Human Telomerase Reverse Transcriptase ( hTERT ) Gene Expression in Thyroid Neoplasms 1

  1999cited by this paper
• Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas

  1998cited by this paper
• Telomerase activity in benign and malignant human thyroid tissues.

  1998cited by this paper
• Telomerase activity in lesions of the thyroid: application to diagnosis of clinical samples including fine-needle aspirates.

  1998cited by this paper
• Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer.

  1998cited by this paper
• Low frequency of positive telomerase activity in a chromophobe subtype of renal cell carcinoma.

  1998cited by this paper
• Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines

  1997cited by this paper
• Effect of pH and ionic strength on the spectrophotometric assessment of nucleic acid purity.

  1997cited by this paper
• Telomerase Catalytic Subunit Homologs from Fission Yeast and Human

  1997cited by this paper
• hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

  1997cited by this paper
• Telomerase activity in benign and malignant human thyroid nodules

  1997cited by this paper
• Telomerase activity in human bladder cancer.

  1996cited by this paper
• Telomerase activity associated with acquisition of malignancy in human colorectal cancer.

  1995cited by this paper
• Differentiated carcinoma of the thyroid with extrathyroidal extension.

  1995cited by this paper
• Telomerase activity in gastric cancer.

  1995cited by this paper
• Prognostic importance of histologic grading in papillary thyroid carcinoma

  1993cited by this paper
• Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.

  1993cited by this paper
• Fundamentals of Biostatistics.

  1992cited by this paper
• Prognostic factors in differentiated carcinoma of the thyroid gland.

  1992cited by this paper
• Avoiding false positives with PCR

  1989cited by this paper
• An expanded view of risk-group definition in differentiated thyroid carcinoma.

  1988cited by this paper
• Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system.

  1987cited by this paper
• Fundamentals of biostatistics

  1982cited by this paper
• Biochemistry of Cancer

  1963cited by this paper

• Comprehensive Assessment of TERT mRNA Expression across a Large Cohort of Benign and Malignant Thyroid Tumours

  2020cites this paper
• EXPRESSÃO DO GENE CITED1 EM CARCINOMA PAPILÍFERO DE TIREÓIDE: UM POTENCIAL MARCADOR DIAGNÓSTICO

  2019cites this paper
• Association between hTERT Polymorphisms and Female Papillary Thyroid Carcinoma.

  2019cites this paper
• The TERT hypermethylated oncologic region predicts recurrence and survival in pancreatic cancer.

  2017cites this paper
• TERT promoter mutations in thyroid cancer.

  2016cites this paper
• Common occurrence of TERT promoter mutations in thyroid cancer

  2016cites this paper
• The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas

  2014cites this paper
• Detection of Telomerase Activity Using a Quantitative Assay and Immunohistochemistry Techniques In Urinary Bladder Lesions

  2012influential citation
• Multifaceted suppression of aggressive behavior of thyroid carcinoma by all-trans retinoic acid induced re-differentiation.

  2011cites this paper
• Molecular markers and bladder carcinoma: Schistosomal and non-schistosomal.

  2011cites this paper
• Carcinogenesis and therapeutic strategies in thyroid cancer.

  2010cites this paper
• Molecular markers in thyroid cancer diagnostics.

  2009cites this paper
• Possible role of telomerase and sFas in pathogenesis of various bladder lesions associated with schistosomiasis.

  2009cites this paper
• Dendritic Cell Based Immunotherapy - A Promising Therapeutic Approach for Endocrine Malignancies

  2008cites this paper